Change in Off-/On-Time After Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone in Patients Who Ended the 1-Year Bipark-I Extension Study on Opicapone 50Mg
AuthID
P-00S-99J
P-00S-99J